Escherichia coli ingested by PMN are promptly growth arrested but undergo limited destruction. We have studied bacterial phospholipid hydrolysis as a possible limiting factor in the disassembly of ingested E. coli, comparing the fates, during phagocytosis by rabbit peritoneal exudate PMN, of three isogenic strains, differing in their content of the pldA gene encoding the principal E. coli phospholipase A (PLA), i.e., pldA-, pldA+, pldA+++ (the latter strain bearing the pldA gene in a multicopy plasmid resulting in a 20-fold increase in PLA content). Ingestion and growth inhibition (> 99% within 15 min) were the same for the three strains, but phospholipid degradation differed according to bacterial PLA content: pldA+++ up to 60%, pldA+ up to 30%, and pidA-up to 20%. Since the pidA-strain has no activatable PLA, phospholipid degradation in this strain demonstrates the action of a PMN PLA. Added PLA2-rich ascitic fluid (AF) or purified AF PLA2 increased the rate and extent of degradation of the pldA-strain, provided the enzyme was added before ingestion was complete.
Introduction
Escherichia coli ingested by PMN are promptly growth arrested but undergo limited destruction. We have studied bacterial phospholipid hydrolysis as a possible limiting factor in the disassembly of ingested E. coli, comparing the fates, during phagocytosis by rabbit peritoneal exudate PMN, of three isogenic strains, differing in their content of the pldA gene encoding the principal E. coli phospholipase A (PLA), i.e., pldA-, pldA+, pldA+++ (the latter strain bearing the pldA gene in a multicopy plasmid resulting in a 20-fold increase in PLA content). Ingestion and growth inhibition (> 99% within 15 min) were the same for the three strains, but phospholipid degradation differed according to bacterial PLA content: pldA+++ up to 60%, pldA+ up to 30%, and pidA-up to 20%. Since the pidA-strain has no activatable PLA, phospholipid degradation in this strain demonstrates the action of a PMN PLA. Added PLA2-rich ascitic fluid (AF) or purified AF PLA2 increased the rate and extent of degradation of the pldA-strain, provided the enzyme was added before ingestion was complete.
125I-AF-PLA2 binds to both E. coli and PMN and thus can enter the vacuole during phagocytosis. Although up to 50-fold more AF-PLA2 than the PLA2 content of the PMN could be loaded into the PMN in this way, degradation of pldA-E. coli did not exceed 30%. Increased phospholipid degradation had no effect on the degradation of bacterial macromolecules. In contrast, bacterial disassembly manifest as structural disorganization, release of bacterial protein derived material, and inhibition of protein synthesis were markedly enhanced when > 50% of prelabelled bacterial phospholipids were degraded. These findings reveal a link between envelope phospholipid degradation and overall bacterial destruction, suggesting therefore that factors limiting PLA action limit the destruction of E. coli ingested by PMN. (J. Clin. Invest. 1990 . 85:1925-1935.) pldA gene -plasmid -mutant Escherichia coli strains * ascitic fluid * phospholipases A2 Ingestion of microorganisms by PMN provides an essential first-line defense against infection and sets the stage for the digestive process that accompanies phagocytosis. However, bacterial macromolecular degradation of organisms such as Escherichia coli and Staphylococcus aureus tends to be only partial (1) (2) (3) (4) . That effective growth arrest by PMN of E. coli occurs with little initial structural and functional disintegration is also indicated by morphological observations (5) and metabolic studies (1, 6) , showing continued macromolecular synthesis despite growth arrest. What prevents more extensive destruction and digestion of ingested bacteria is not clear, because PMN contain in their granules a broad-spectrum digestive apparatus, that is delivered early into the phagocytic vacuole during degranulation (7) (8) (9) . Moreover, under adverse conditions bacteria activate autolytic enzymes (10).
Phospholipids are among the constituents of E. coli that undergo limited degradation during phagocytosis (1, 11, 12) , raising the possibility that the rate and extent of breakdown of these structural envelope elements determine in part the effectiveness of bacterial destruction.
We have shown before, by comparing phospholipid hydrolysis in wild-type E. coli and in a mutant strain lacking activatable phospholipases, that the phospholipolytic enzymes of the PMN as well as of E. coli itself can degrade the bacterial phospholipids (1 1, 13, 14) . Isolated bactericidal agents such as the bactericidal permeability-increasing protein (BPI)' and the antibiotic polymyxin B, also trigger bacterial phospholipid degradation by both endogenous and exogenous phospholipases (15, 16) . The more envelope disruptive the agent the more extensive the hydrolysis, presumably because of greater phospholipase access to various bacterial phospholipid pools (15) .
In this study we aimed at (a) identifying the phospholipases participating in breakdown of the phospholipids of E. coli ingested and killed by rabbit peritoneal exudate PMN, (b) determining the factors that limit their action, and (c) establishing by morphologic and biochemical criteria the relationship between varying levels of phospholipid hydrolysis and the rate and extent of destruction of ingested E. coli.
We have taken advantage of the availability of three isogenic E. coli strains differing in their content of the pldA gene encoding the principal deacylating phospholipase (A) (PLA) of E. coli (17) .
We show the participation of three defined PLA in the attack on the phospholipids of the ingested E. coli: the pldA gene product of E. coli, a PMN PLA2, and a PLA2 present in the cell-free (ascitic) fluid of the inflammatory exudate (18) . We also show that the speed and extent of disassembly of ingested E. coli are increased when bacterial phospholipid degradation during phagocytosis is amplified by increasing the bacterial phospholipase content. These findings suggest therefore that the more limited phospholipid degradation produced under normal circumstances limits destruction of ingested E. coli by PMN.
Methods
Collection of ascitic fluid (AF) and PMN. Sterile inflammatory exudates were collected from New Zealand White rabbits 14-16 h after intraperitoneal injection with of 250-300 ml of glycogen-saturated saline (1). Cells were sedimented by centrifugation at 100 g for 10 min and resuspended in Hanks' buffered salt solution (HBSS, without phenol red, Microbiological Associates, Bethesda, MD) to a final concentration of 108/ml. The cell-free supernatant was spun at 20,000 g for 30 min to yield AF. Cell suspensions contained > 90% PMN as judged by differential counting.
Preparation ofPMN sonicates. PMN were disrupted by sonication (60 W, 15 s, 0-40C, cell disrupter, Branson Sonic Power Co., Danbury, CT). The efficiency of sonication was monitored by light microscopy.
Growth of E. coli. The E. coli strains used were 1303 (pldA-, lacking the principal envelope phospholipase), 1602 (pldA+, wild-type strain), and I 303pPI232 (pldA+++), a phospholipase-rich strain containing the pldA gene product in 20-fold excess in a multicopy plasmid (17) . E. coli were cultured in phosphate-buffered yeast broth (Difco Laboratories, Detroit, MI) (pH 7.3), or in nutrient broth (Difco Laboratories) (pH 7.3). Growth media were supplemented with 50 Mg/ml chloramphenicol (Parke-Davis, Morris Plains, NJ) for growth ofE. coli 1303 pPIl232 to select for bacteria containing the plasmid encoding the pld A gene product and chloramphenicol resistance. Bacterial cultures were grown overnight to stationary phase and were then subcultured for 2-3 h in fresh growth medium (diluted 1:10), at 370C. Bacterial concentrations were determined by measuring absorbance at 550 nm with a Coleman junior spectrophotometer. The bacteria were sedimented by centrifugation at 6,000 g for 10 min and resuspended in sterile physiological saline to a final concentration of 109/ml. (21) , and the samples were spun at 100 g for 7 min to separate ingested and extracellular bacteria. The pellet was washed twice with 1% BSA in HBSS to remove trapped and loosely adherent bacteria. The distribution of the radiolabel was determined by measuring aliquots of the recovered supernatants and the final resuspended cell pellet by liquid scintillation counting. There was no detectable conversion of radiolabeled material from trichloroacetic acid (TCA)-precipitable to a TCAsoluble form during the course ofthe incubation. Uptake (ingestion) is expressed as the percentage of the total recovered radioactivity that is associated with the cell pellet. Recovery of total radioactivity was 2 90%.
Assay ofbacterial protein synthesis. To measure bacterial protein synthesis, the standard incubation mixture was supplemented with 0.5 mM cycloheximide (to inhibit protein synthesis by the PMN) and 0.1% casamino acids (Difco Laboratories) (1) . At various times, L-'4C amino acids (20 gCi/ml final concentration) were added and the mixtures were incubated for an additional 30 min. Reactions were terminated by the addition of 250 ul of ice-cold 20% TCA. TCA-precipitable material was collected by filtration through a 0.45-Mm Millipore HAWP membrane, washed three times with 1 ml 10% ice-cold TCA, and measured by liquid scintillation counting. Protein synthesis is expressed as the percentage of the amino acid incorporated into TCAprecipitable material by untreated E. coli in the first 30 min.
Assay ofdegradation ofbacterial macromolecules. Prelabeled bacteria (5 X 107) were incubated with or without PMN (5 X 106) (or whole PMN sonicate where indicated) in standard incubation mixtures. At the times indicated, reactions were terminated by the addition of 250 ul of ice-cold TCA and placed at 4VC for at least 30 min. TCA-precipitable material was collected and counted as described above. Degradation is expressed as a percent ofthe initial TCA-precipitable radioactivity converted to TCA-soluble form.
Assay ofrelease ofbacterial protein-derived material. E. coli prelabeled with`4C-or 35S-amino acids were incubated with either PMN or whole PMN sonicate in standard incubation mixtures. At various times incubations were terminated by spinning in an Eppendorf microfuge for 2 min to pellet E. coli. Radiolabel released into the supernatant was quantitated by liquid scintillation counting before and after precipitation with TCA.
Electron microscopy. E. coli prelabeled with [14C]oleate were incubated at 37°C for up to 3 h in standard incubation mixtures with a bacteria/PMN ratio of 50:1. Bacterial viability and phospholipid degradation at this ratio were the same as at a ratio of 10:1. For electron microscopy cells were sedimented by centrifugation and the pellets were resuspended in 2.5% glutaraldehyde in Kellenberger's veronal acetate buffer (22) , pH 6.1 and fixed for 2 h at 10°C. The cells were then washed three times with the veronal acetate buffer and postfixed with 1% osmium tetroxide in the same buffer for 16 h at 10°C. Cells were stained with uranyl magnesium acetate (0.5%) for 1 h at 20°C and embedded in 1% noble agar. The agar-embedded blocks were dehydrated in increasing concentrations of ethyl alcohol, which was replaced with propylene oxide as a last step. Specimens were infiltrated and embedded in a low-viscosity spurr epoxy resin (Polysciences Inc., Warrington, PA), and thin sections were obtained with an ultratome (using a diamond knife; LKB Instruments, Inc., Gaithersburg, MD ute to the degradation of bacterial phospholipids during phagocytosis.
Action ofAFPLA2 on E. coli pldA-during phagocytosis by PMN. PMN-rich inflammatory peritoneal exudates also contain large amounts of an extracellular (AF) PLA2 ( 18) that is closely similar to a PMN PLA2 that has been isolated recently in this laboratory (24) . To determine whether this PLA2 could also contribute to bacterial phospholipolysis during phagocytosis, we compared phospholipid degradation in the pldAstrain during incubation with PMN in the presence and absence of added AF PLA2. AF PLA2 added either as the purified enzyme or as whole AF caused a dose-dependent increase in the degradation ofbacterial phospholipids by PMN (Fig. 2) . In the absence of added PLA2 only 7% of the bacterial phospholipids were degraded during 60-min incubations, compared with 30% in the presence of added enzyme. The effect of the purified enzyme was less than that of the crude AF indicating that other factors in the inflammatory exudate contribute to the PLA2 action. In the absence of PMN, purified enzyme alone had no detectable effect on either bacterial viability or phospholipid degradation, showing that the action of this extracellular enzyme depended on the presence of PMN.
Evidence that extracellular AF PLA2 is acting on intracellular E. coli. The PMN-dependent action of the AF PLA2 raised the possibility that the extracellular enzyme acted on ingested bacteria. Parallel assays of bacterial colony-forming ability and uptake demonstrated that inhibition of bacterial multiplication coincided with bacterial uptake by the PMN (correlation coefficient = 0.96) (Fig. 3) . Whereas inhibition of bacterial colony formation, and hence ingestion, were complete within 15-30 min, degradation of bacterial phospholipids continued for up to 60 min (Fig. 4) Figure 3 . Correlation between uptake and viability of bacteria incubated with PMN.
[3H]Thymidine-labeled E. coli pldA-(2.5 x 107) and rabbit PMN (5 X 106) were incubated at 37°C as described in Methods, and at various times uptake and bacterial viability were determined. Uptake is expressed as the percentage of total bacterial radioactivity which is associated with the PMN: there was no degradation of bacterial DNA as judged by the recovery of acid precipitable radioactivity. The line drawn represents the best fit determined by linear regression analysis (r = 0.96). PMN-associated bacteria were indeed intracellular and suggests that the action of the AF PLA2 may require co-internalization of the enzyme with the bacteria.
Mechanism of internalization of an extracellular enzyme. The PLA2 could be internalized as a component of the ingested extracellular fluid, or if bound to the E. coli and/or PMN. Incubation of increasing amounts of 1251I-AF PLA2 with E. coli pldA-for 15 min at 370C resulted in binding of nearly 50% ofthe added PLA2 over the entire PLA2 dose range tested (up to 60,000 U (-300 ng)/2.5 X 107 E. coli). Binding was maximal within 15 min and did not increase during longer incubations. PLA2 binding was the same when either whole AF or purified PLA2 was added (Fig. 5) indicating that no other exudate proteins were required to promote PLA2 binding. Precoating of E. coli pldA-with increasing amounts of PLA2 enhanced bacterial phospholipid degradation during phagocytosis by PMN in a manner similar to that seen when purified enzyme or whole AF was added directly to the incubation mixture ( Fig. 5 ; compare with Fig. 2) , indicating that the bound PLA2 contributed to the digestion ofingested bacteria. Note that despite the delivery of increasing amounts of bound PLA2 on the ingested E. coli, phospholipid degradation did not exceed 35% indicating additional constraints on phospholipase action.
Incubation of PMN with '251I-AF PLA2 and purified unlabeled PLA2 or whole AF resulted in binding of substantial amounts of the added PLA2 (data not shown). Precoating of PMN with PLA2 also enhanced phospholipolysis ofingested E. coli pldA-from 7.0±0.5% (n = 12) to 35%±1.0 (n = 7). Precoating of PMN in addition to precoating of E. coli did not further increase bacterial phospholipid degradation. It appears therefore that the extracellular phospholipase can enter the phagocytic vacuole either "piggy-back" on the E. coli or on invaginated PMN plasma membrane and, once inside, can contribute to the hydrolysis of the bacterial phospholipids. (Fig. 6 ). Thus pools of bacterial phospholipid not degraded by the bacterial PLA are also refractory to the added AF PLA2-Effect ofbacterial phospholipid degradation on the degradation ofbacterial macromolecules. To determine the effect of bacterial phospholipid degradation on the breakdown of other bacterial constituents, we compared the degradation of prelabeled protein, RNA and peptidoglycan in E. coli strains pldA-, pldA+, pldA+++ during the course of incubation. E. coli incubated alone showed no net degradation (loss of acidprecipitable radioactivity) of these three radiolabeled macromolecules. However, as shown before, during phagocytosis all these bacterial constituents underwent prompt and similar degradation that reached a plateau after 30 mins at 50% (1).
Degradation was the same in the three strains indicating that increased phospholipid degradation had no noticeable effect on bacterial macromolecular degradation (Table I) .
Effect ofphospholipid degradation on bacterialprotein synthesis. The effect of enhanced phospholipid degradation on bacterial metabolism was assessed by measuring protein synthesis in the three strains during phagocytosis by PMN (Fig. 7) . Although ingestion and growth arrest of the three strains were complete within 30 mins (Fig. 1) , protein synthesis by the pldA-and pldA+ strains was only modestly inhibited even after incubation for up to 3 h. In contrast, protein synthesis by the pldA+++ strain was inhibited more promptly and markedly, both by about fourfold (Fig. 7) .
Effect ofphospholipid degradation on the release ofbacterial protein during killing by intact PMN and whole PMN sonicates. Effects on amino acid uptake and incorporation into protein, a process which requires an intact cytoplasmic membrane implies that increased phospholipid degradation may result in disruption of the energy-producing apparatus and the overall structural integrity of the bacteria. As a crude index of bacterial disintegration we measured the release of prelabeled bacterial protein-derived material. Fig. 8 A shows the time course of phospholipid degradation and release of protein-derived material from the three E. coli strains during incubation with intact PMN. In the absence of PMN there was minimal release of labeled material (< 10%) which was mostly acid soluble. During phagocytosis protein release from the pldA+++ strain was markedly stimulated, but very limited from the pldA-or pldA+ strains. Up to 50% of the released material was acid precipitable, i.e., as intact protein or as large fragments.
Estimates of protein release from ingested E. coli are complicated because protein released from the bacteria may also have to traverse PMN phagolysosomal and plasma membrane barriers to reach the extracellular medium. To measure more directly release of protein-derived material from E. coli further studies were carried out with whole PMN sonicates that are as growth inhibitory against E. coli as intact PMN (1, 25, 26) .
When incubated with fully growth inhibitory concentrations of whole PMN were also similar to those obtained with intact cells; 40% in the pldA+++ strain compared to . 4% in both the pIdA-and pldA+ strains (Fig. 8 B) . Release was maximal within 30-60 min in contrast to the 6-8 h seen with intact PMN. All of the released material was acid precipitable, reflecting the lack of protein-degradative activity of PMN sonicate toward E. coil (27) .
Effect of increased phospholipid degradation on the fine structure of ingested E. coli. To monitor more directly the structural integrity of ingested E. coli in relation to bacterial phospholipid degradation, thin sections of PMN-E. coli suspensions after incubation for up to 3 h were prepared for elec- Phospholipid degradation (open symbols, top panels) and release of bacterial protein-derived material (solid symbols, bottom panels) were measured as described in Methods. Viability of E. coli treated with either intact PMN or PMN sonicates was < 1% of untreated E. coli. tron microscopy. After 30 min of incubation 84% of the ingested E. coli pldA-showed little or no detectable ultrastructural alteration (Table II) . Only after 3 h of incubation was more extensive damage (consisting of gross plasmolysis with condensation of cytoplasmic contents and ghost formation and/or lysis) apparent in the majority of the bacterial population (compare Fig. 9 , A and B; Table II ). Addition ofAF PLA2 during ingestion of E. coli pldA-did not markedly accelerate or amplify the ultrastructural disintegration. In contrast, -70% of ingested E. coli pldA+++ showed signs ofextensive damage after only 30 min of incubation which progressed over the course of 3 h (Fig. 9, C and D ; Table II) . Thus, when > 50% ofthe bacterial phospholipids are degraded, overall destruction is more rapid and pronounced. The morphology ofthe PMN is also dramatically altered; evident as giant phagolysosomes containing multiple bacteria or bacterial remnants and near complete degranulation (Fig. 9, C and D) .
Discussion
These studies of bacterial phospholipid degradation during the interaction of rabbit PMN with three isogenic E. coli strains, genetically manipulated to vary their content of the principal E. coli PLA, provide new insights into (a) the determinants of the phospholipid degradation that is part of the post-phagocytic process and (b) its role in the overall destruction of ingested E. coli.
Identification of PLA participating in bacterial phospholipolysis. In the inflammatory environment, phospholipid-degrading enzymes are present in the cellular and extracellular elements mobilized by the host in response to microbial invasion (28, 29) , as well as in the target bacteria (1 1). Among the many classes of phospholipases present in prokaryotic and eukaryotic cells and fluids (30, 3 1) , we have identified three deacylating phospholipases (PLA) that participate in the hydroly- The experiment was carried out as described in Methods. Intracellular bacteria were counted and evaluated for structural alterations: 0, intact bacteria; 1+, plasmolysis; 2+, gross plasmolysis with condensation of cytoplasmic contents; 3+, ghost formation and/or lysis. The data in the table indicate the percentage of bacteria displaying these structural changes. At least 100 bacteria of each strain were evaluated for each time point and results are presented as the percentage of total bacteria evaluated at each time point. Sections were evaluated by three independent observers and the standard error of these determinations was < 2% for each time point.
sis of the phospholipids of ingested E. coli: the pldA gene product encoding an E. coli PLA with limited substrate specificity (17, 32, 33) , and two PLA2 that are structurally and functionally closely similar-(a) a well-defined protein present in the cell-free fluid of sterile inflammatory exudates produced in the peritoneal cavity of rabbits (34), and (b) a granule associated PMN PLA2 that has been purified recently to homogeneity (24) . Under the conditions of these experiments the contribution oflysophospholipases has been minimized by the use of albumin in the incubation mixture. Albumin is an effective trapping agent ofboth free fatty acids and lysocompounds and thereby removes the lysophospholipase substrate (19) . Since no labeled diglyceride or phosphatidic acid accumulates, neither phospholipase C (PLC) nor phospholipase D (PLD) appears to be involved in the attack on the E. coli phospholipids.
The bacterial PLA plays the dominant role in the hydrolysis ofthe phospholipids of ingested E. colh. The comparison of the three isogenic E. coli strains establishes that among the several phospholipases that have been identified in E. col, it is the pldA gene product that is activated during phagocytosis. Two PLA genes have been identified by Nojima and Doi and their co-workers (35, 36) in E. col, one encoding a detergentsensitive PLA (dsPLA), and the other a detergent-resistant PLA (drPLA). The E. coli mutant (1303, pldA-) used in this study only lacks the gene for the drPLA (17) . However, since this strain shows no hydrolysis when exposed to bactericidal agents such as BPI and polymyxin B (unpublished observations), it follows that the drPLA is the enzyme that is activated under adverse conditions. Moreover, the insertion of multiple copies of the pldA gene in this mutant, resulting in a 20-fold increase in PLA content relative to the wild type-parent strain (1602, pldA+), increased bacterial phospholipid degradation in response to either PMN (Fig. 1) , BPI, or polymyxin B (Weiss et al., manuscript in preparation). It should be noted that under physiological conditions, the presence of a large excess of this gene product has no effect on the phospholipids nor on the growth of the organism, indicating that the characteristic tight control of this enzyme remains intact in the absence of major perturbations.
The use ofthe pldA-strain and analysis of the radioactive products ofhydrolysis ofboth '4C-16:0 and "4C-18:1 labeled E. coli phospholipids in this and our earlier studies (13) also implicate two host PLA2 in the observed degradation. One of these is a PMN PLA2, acting on the ingested E. coli when no other PLA are in evidence. A novel finding is that the PLA2 present in the cell-free fluid of the peritoneal exudate also contributes to the phospholipolysis of ingested E. coli. Addition of this PLA2 produced a dose-dependent increase in the phospholipid degradation of ingested E. coli pldA- (Figs. 2  and 4 ). This is remarkable because it demonstrates that a component present in the fluid phase ofthe inflammatory environment can be translocated into the phagolysosome via the ingested E. coli and/or invaginated PMN membrane, and once internalized can contribute to bacterial degradation.
These findings indicate that the extent of bacterial phospholipid degraded during phagocytosis is a function of the amount of available bacterial PLA or host PLA2. Apparently the closely related AF PLA2 (24) can supplement limiting amounts of cellular PLA2. However, other factors also limit bacterial phospholipid hydrolysis. Thus, (a) a 20-fold increase in bacterial PLA only increases phospholipid degradation twofold, to a maximum of 60% (Fig. 1) ; (b) addition of large amounts of AF PLA2 caused proportionally increased enzyme binding, but no further increase in hydrolysis (Fig. 5) ; (c) addition of large amounts of AF PLA2 to E. coli pldA+ and pldA+++ also did not further increase phospholipolysis (Fig.  6 ). These results imply that substantial pools of the bacterial phospholipids remain inaccessible to PLA action, even in the pldA+++ strain. In both the wild-type and in the pldA+++ strains the pldA gene product is tightly and exclusively associated with the outer membrane (17, 33) , suggesting that the accessible phospholipid substrate is mainly limited to that portion of the envelope lipid that is located in the outer membrane (about half) (37) . Because bacterial and host PLA actions are not additive, the phospholipids in the inner membrane may also be less accessible to the PMN and AF PLA2.
What triggers bacterial phospholipolysis during phagocytosis by PMN? Neither endogenous nor exogenous phospholipases cause detectable phospholipid degradation in unperturbed E. coli (1 1, 38, 39) . The action of all three phospholipases on E. coli is triggered by agents and conditions associated with membrane perturbation or bacterial trauma (40). A major component of the complex antimicrobial arsenal of the PMN is the BPI (1 1). Effects of BPI on gram-negative bacteria include prompt growth inhibition, an immediate breakdown of the outer membrane permeability barrier, and activation of bacterial phospholipases and ofa few selected exogenous PLA2 (e.g., of PMN and AF) (14, 19, 39-41). The prolonged preservation of bacterial protein synthesis and incomplete phospholipid degradation seen when E. coli are ingested by PMN are also typical of BPI action (25). These remarkable similarities between the initial injuries inflicted by isolated BPI and by intact PMN, together with the evidence that BPI binds to ingested E. coli (42) , are compatible with the hypothesis that BPI accounts for PLA activation during phagocytosis.
Effect of phospholipid degradation on the overall fate of ingested E. coli. We have previously proposed that limited phospholipid hydrolysis may be a factor in limiting overall digestion and destruction of ingested E. coli (1, 10) . This study, using three E. coli strains that were equally effectively ingested and growth arrested, but that underwent different levels of phospholipolysis, supports this contention. When phospholipid hydrolysis is increased beyond the level that can be retched during phagocytosis of the wild-type strain, by raising the bacterial PLA content through genetic manipulation, overall destruction is markedly enhanced. This shows for the first time that phospholipid degradation can play a major role in subsequent disassembly of the ingested E. coli, thereby contributing to the ultimate disposal of the killed bacteria. This is best illustrated by comparison of the ultrastructural appearance of ingested E. colt pldA-and of E. coli pldA+++ (Fig. 9, B and C). The release of bacterial protein-derived material and the more rapid inhibition of protein synthesis by the ingested E. coli pldA+++ also provides biochemical evidence that more extensive bacterial phospholipid hydrolysis during phagocytosis is accompanied by gross envelope alterations that are not apparent at lower levels of phospholipolysis. The substantial extracellular release of TCA-precipitable radiolabeled material from ingested "'C-amino acid-labeled E. coli pldA+++ (Fig. 8) may also point to structural alterations in the PMN membranes. Profound morphologic changes are indeed seen in the PMN that ingested pldA+++ E. col, consisting ofgiant vacuoles, presumably formed by fusion of multiple smaller phagosomes, and the absence of recognizable granules at 30 min (compare Fig. 9 , A and C). These observations suggest that the activation of the increased bacterial PLA content of the plasmid-carrying E. coli has deleterious effects not only on the ingested bacteria, but also on the phagocyte. How the effect on the PMN is mediated is not yet clear.
Release of "'C-amino acid-labeled material from the pldA+ strain during exposure to either intact PMN or broken PMN was no greater than from the pldA-strain, despite a substantial difference in phospholipid degradation (Fig. 8 ). This suggests that there is not simply a graded effect of phospholipid degradation on the extent ofbacterial destruction, but rather that major structural alterations do not become apparent until a critical threshold of phospholipid hydrolysis is reached or certain pools are degraded. Further, bacterial phospholipid synthesis continues and may be stimulated, when phospholipolysis is triggered in E. coli growth-inhibited by cell-free PMN preparations. However, when hydrolysis exceeds 50% phospholipid biosynthesis is inhibited (Weiss et al., manuscript in preparation). Therefore, the ability ofthe bacteria to compensate for phospholipid breakdown by synthesis may temper the structural consequences of phospholipase action.
Two sets of observations (not shown) establish that the more pronounced envelope alterations during phagocytosis of the pldA+++ strain are linked to increased phospholipid degradation and not to the presence of a high copy plasmid: First, during phagocytosis, two pldA-E. coli strains containing a high-copy plasmid (a) E. coli pPI2342, bearing the same plasmid as E. coli pPI232 but with an insertion mutation resulting in an inactive truncated gene product, and (b) E. coli pBR322 carrying an unrelated plasmid, are as resistant to destruction as are the pldA-and the pldA+ strains. Secondly, the structural alterations observed in the pldA+++ strain can be reproduced in the pldA-strain treated with bactericidal concentrations of cell-free PMN fractions supplemented with purified AF PLA2 in amounts that cause the same high level of phospholipolysis.
In striking contrast to the enhanced hydrolysis of phospholipid and the release of more bacterial protein-derived material during phagocytosis of the pldA+++ E. coli, compared with the pldA+ and pldA-strains, degradation of specifically labeled bacterial protein, RNA, and peptidoglycan of the three strains is not appreciably different. Apparently, the more extensive bacterial destruction does not imply greater effectiveness of the degradative enzymes of bacteria and host acting on these macromolecules. However, we cannot yet exclude subtle differences in the degree of fragmentation of the macromolecules of the three strains during phagocytosis.
In conclusion, these studies support our previous contention that in the interaction between PMN and bacteria, phospholipid hydrolysis may be a limiting factor in the rate and extent of bacterial destruction. Hence, the finding that a PLA2 in the cell-free fluid ofthe inflammatory exudate enhances the degradation of the phospholipids of the internalized E. coli points to an integrated host-defense system in which disassembly of invading microorganisms while initiated, but only partly executed, by the short-lived PMN is amplified by extracellular factors and may be continued by longer-lived scavenger cells that appear on the inflammatory scene later. Alternatively, bacterial remnants remain in the host environment with potentially pathologic consequences, or to maintain immunological responses. These concepts are now ready for further exploration.
